← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2012Last known activity
Apr 12, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 6 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT07001709Lead sponsorPhase 4Apr 12, 2024
- NCT04481256CollaboratorN/AOct 1, 2020
- NCT01876355Reponsible party - principal investigatorPhase 3Jan 1, 2018
- NCT01876355Lead sponsorPhase 3Jan 1, 2018
- NCT05693688CollaboratorPhase 4Dec 1, 2017
- NCT02466373Reponsible party - principal investigatorPhase 3Dec 1, 2016
- NCT02466373Overall official - principal investigatorPhase 3Dec 1, 2016
- NCT02466373Lead sponsorPhase 3Dec 1, 2016
- NCT01362959CollaboratorPhase 4Jun 1, 2012
Details
- Last known activity
- Apr 12, 2024